PLASMA DISPOSITION OF PROCHLORPERAZINE AND GENDER AFFECT ITS ANTIEMETIC EFFECT AND PROLACTIN SECRETION IN CANCER PAIN PATIENTS TREATED WITH OXYCODONE
- In: Poster Session
- At: Düsseldorf (Germany) (2015)
- Type: Poster
- By: TASHIRO, Masaki (Hamamatsu University Hospital, Hospital Pharmacy, Hamamatsu, Japan)
- Co-author(s): Masaki Tashiro
Prochlorperazine (PCPZ), a dopamine receptor D2 antagonist, is used for the antiemetic treatment of opioid-induced nausea and vomiting. Few clinical reports have been published on the interindividual variations in the clinical responses to PCPZ in opioid analgesics treated cancer patients.
Sixty-one cancer pain patients receiving PCPZ concomitantly.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.